New Results
Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity
View ORCID ProfileDmitri Rozanov, Anton Cheltsov, Aaron Nilsen, Christopher Boniface, James Korkola, Joe Gray, Jeffrey Tyner, Cristina E. Tognon, Gordon B. Mills, Paul Spellman
doi: https://doi.org/10.1101/432252
Dmitri Rozanov
1Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon
Anton Cheltsov
2Q-MOL LLC, San Diego, CA
Aaron Nilsen
3Medicinal Chemistry Core, Oregon Health and Science University, Portland, Oregon
Christopher Boniface
1Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon
James Korkola
4Department of Biomedical Engineering, Oregon Health and Science University, Portland, Oregon
Joe Gray
4Department of Biomedical Engineering, Oregon Health and Science University, Portland, Oregon
Jeffrey Tyner
5Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon
Cristina E. Tognon
5Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon
6Howard Hughes Medical Institute, Portland, Oregon
7Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR 97239
Gordon B. Mills
5Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, Oregon
Paul Spellman
1Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon
Article usage
Posted October 01, 2018.
Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity
Dmitri Rozanov, Anton Cheltsov, Aaron Nilsen, Christopher Boniface, James Korkola, Joe Gray, Jeffrey Tyner, Cristina E. Tognon, Gordon B. Mills, Paul Spellman
bioRxiv 432252; doi: https://doi.org/10.1101/432252
Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity
Dmitri Rozanov, Anton Cheltsov, Aaron Nilsen, Christopher Boniface, James Korkola, Joe Gray, Jeffrey Tyner, Cristina E. Tognon, Gordon B. Mills, Paul Spellman
bioRxiv 432252; doi: https://doi.org/10.1101/432252
Subject Area
Subject Areas
- Biochemistry (11561)
- Bioengineering (8622)
- Bioinformatics (28861)
- Biophysics (14793)
- Cancer Biology (11918)
- Cell Biology (17159)
- Clinical Trials (138)
- Developmental Biology (9302)
- Ecology (14019)
- Epidemiology (2067)
- Evolutionary Biology (18128)
- Genetics (12144)
- Genomics (16615)
- Immunology (11706)
- Microbiology (27689)
- Molecular Biology (11384)
- Neuroscience (60089)
- Paleontology (447)
- Pathology (1847)
- Pharmacology and Toxicology (3183)
- Physiology (4878)
- Plant Biology (10276)
- Synthetic Biology (2849)
- Systems Biology (7289)
- Zoology (1618)